These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29759672)

  • 1. Read My Lips: A Positive Ajmaline Test Does Not Always Mean You Have Brugada Syndrome.
    Viskin S; Rosso R
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1409-1411. PubMed ID: 29759672
    [No Abstract]   [Full Text] [Related]  

  • 2. A Report of Brugada Syndrome Presenting with Cardiac Arrest Triggered by Verapamil Intoxication.
    Yakut K; Erdoğan İ; Varan B; Atar İ
    Balkan Med J; 2017 Dec; 34(6):576-579. PubMed ID: 29215340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yield and Pitfalls of Ajmaline Testing in the Evaluation of Unexplained Cardiac Arrest and Sudden Unexplained Death: Single-Center Experience With 482 Families.
    Tadros R; Nannenberg EA; Lieve KV; Škorić-Milosavljević D; Lahrouchi N; Lekanne Deprez RH; Vendrik J; Reckman YJ; Postema PG; Amin AS; Bezzina CR; Wilde AAM; Tan HL
    JACC Clin Electrophysiol; 2017 Dec; 3(12):1400-1408. PubMed ID: 29759671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Ajmaline and Procainamide Provocation Tests in the Diagnosis of Brugada Syndrome.
    Cheung CC; Mellor G; Deyell MW; Ensam B; Batchvarov V; Papadakis M; Roberts JD; Leather R; Sanatani S; Healey JS; Chauhan VS; Birnie DH; Champagne J; Angaran P; Klein GJ; Yee R; Simpson CS; Talajic M; Gardner M; Yeung-Lai-Wah JA; Chakrabarti S; Laksman ZW; Sharma S; Behr ER; Krahn AD
    JACC Clin Electrophysiol; 2019 Apr; 5(4):504-512. PubMed ID: 31000106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual phenotypic transmission in Brugada syndrome.
    Hermida JS; Arnalsteen-Dassonvalle E; Kubala M; Mathiron A; Traulle S; Anbazhagan K; Hermida A; Rochette J
    Arch Cardiovasc Dis; 2013; 106(6-7):366-72. PubMed ID: 23810369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the mechanism of Brugada syndrome: epicardial substrate and modification during ajmaline testing.
    Sacher F; Jesel L; Jais P; Haïssaguerre M
    Heart Rhythm; 2014 Apr; 11(4):732-4. PubMed ID: 23732228
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug Provocation Testing in Brugada Syndrome: A Test of Uncertain Significance.
    Sun AY
    JACC Clin Electrophysiol; 2019 Apr; 5(4):513-515. PubMed ID: 31000107
    [No Abstract]   [Full Text] [Related]  

  • 8. Is a drug-challenge test with propafenone adequate to exclude Brugada syndrome?
    Yildiz BS; Gungor H; Gul I; Bilgin M; Zoghi M; Akilli A
    Cardiovasc J Afr; 2013 Mar; 24(2):e4-6. PubMed ID: 23613002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brugada-like changes in the peripheral leads during diagnostic ajmaline test in patients with suspected Brugada syndrome.
    Batchvarov VN; Govindan M; Camm AJ; Behr ER
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):695-703. PubMed ID: 19545329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should all individuals with a nondiagnostic Brugada-electrocardiogram undergo sodium-channel blocker test?
    Zorzi A; Migliore F; Marras E; Marinelli A; Baritussio A; Allocca G; Leoni L; Perazzolo Marra M; Basso C; Buja G; Thiene G; Iliceto S; Delise P; Corrado D
    Heart Rhythm; 2012 Jun; 9(6):909-16. PubMed ID: 22334153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrical Substrate Elimination in 135 Consecutive Patients With Brugada Syndrome.
    Pappone C; Brugada J; Vicedomini G; Ciconte G; Manguso F; Saviano M; Vitale R; Cuko A; Giannelli L; Calovic Z; Conti M; Pozzi P; Natalizia A; Crisà S; Borrelli V; Brugada R; Sarquella-Brugada G; Guazzi M; Frigiola A; Menicanti L; Santinelli V
    Circ Arrhythm Electrophysiol; 2017 May; 10(5):e005053. PubMed ID: 28500178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual response to the ajmaline test in a patient with Brugada syndrome.
    Castro Hevia J; Dorticos Balea F; Dorantes Sánchez M; Zayas Molina R; Quiñones Pérez MA
    Europace; 2003 Oct; 5(4):371-3. PubMed ID: 14753634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous implantable cardioverter-defibrillator and drug-induced Brugada syndrome: the importance of repeat morphology analysis during ajmaline challenge.
    Conte G; Regoli F; Moccetti T; Auricchio A
    Eur Heart J; 2016 May; 37(19):1498. PubMed ID: 26530106
    [No Abstract]   [Full Text] [Related]  

  • 14. Ventricular arrhythmia during ajmaline challenge for the Brugada syndrome.
    Dobbels B; De Cleen D; Ector J
    Europace; 2016 Oct; 18(10):1501-1506. PubMed ID: 26941343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of QRS prolongation during diagnostic ajmaline test in patients with suspected Brugada syndrome.
    Batchvarov VN; Govindan M; Camm AJ; Behr ER
    Heart Rhythm; 2009 May; 6(5):625-31. PubMed ID: 19389649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous drug challenge using flecainide and ajmaline in patients with Brugada syndrome.
    Wolpert C; Echternach C; Veltmann C; Antzelevitch C; Thomas GP; Spehl S; Streitner F; Kuschyk J; Schimpf R; Haase KK; Borggrefe M
    Heart Rhythm; 2005 Mar; 2(3):254-60. PubMed ID: 15851314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ajmaline challenge in Brugada syndrome: diagnostic impact, safety, and recommended protocol.
    Rolf S; Bruns HJ; Wichter T; Kirchhof P; Ribbing M; Wasmer K; Paul M; Breithardt G; Haverkamp W; Eckardt L
    Eur Heart J; 2003 Jun; 24(12):1104-12. PubMed ID: 12804924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myotonic dystrophy type 1 mimics and exacerbates Brugada phenotype induced by Nav1.5 sodium channel loss-of-function mutation.
    Pambrun T; Mercier A; Chatelier A; Patri S; Schott JJ; Le Scouarnec S; Chahine M; Degand B; Bois P
    Heart Rhythm; 2014 Aug; 11(8):1393-400. PubMed ID: 24768612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of intracardiac electrogram with surface electrocardiogram in Brugada syndrome patients.
    Probst V; Sacher F; Derval N; Gourraud JB; Mabo P; Medkour F; Le Marec H; Gill J
    Europace; 2014 Jun; 16(6):908-13. PubMed ID: 24068444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to intravenous ajmaline: a retrospective analysis of 677 ajmaline challenges.
    Veltmann C; Wolpert C; Sacher F; Mabo P; Schimpf R; Streitner F; Brade J; Kyndt F; Kuschyk J; Le Marec H; Borggrefe M; Probst V
    Europace; 2009 Oct; 11(10):1345-52. PubMed ID: 19589796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.